Shigeru Saito

Shigeru Saito

Auto-generated profile, based on publicly available information

Shigeru Saito

Department of Cardiology, Shonan Kamakura General Hospital , 1370-1 Okamoto, Kamakura, Kanagawa 247-8533

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 1999 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SSShigeru Saito
Shigeru Saito
HIHajime Ikei
Hajime Ikei
GHGeorge Hosokawa
George Hosokawa
STShinji Tanaka
Shinji Tanaka

1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
PDF file
SSShigeru Saito
Shigeru Saito
TITakaaki Isshiki
Takaaki Isshiki
TKTakeshi Kimura
Takeshi Kimura
HOHisao Ogawa
Hisao Ogawa
HYHiroyoshi Yokoi
Hiroyoshi Yokoi
MNMasato Nakamura
Masato Nakamura
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

18 June 2003 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SSShigeru Saito
Shigeru Saito
STShinji Tanaka
Shinji Tanaka
YHYoshitaka Hiroe
Yoshitaka Hiroe
YMYusuke Miyashita
Yusuke Miyashita
STSaeko Takahashi
Saeko Takahashi
KTKazushi Tanaka
Kazushi Tanaka

21 April 2003 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SSShigeru Saito
Shigeru Saito
STShinji Tanaka
Shinji Tanaka
YHYoshitaka Hiroe
Yoshitaka Hiroe
YMYusuke Miyashita
Yusuke Miyashita
STSaeko Takahashi
Saeko Takahashi
SSShutaro Satake
Shutaro Satake

15 March 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
TKTsuyoshi Kaneko
Tsuyoshi Kaneko
SVSreekanth Vemulapalli
Sreekanth Vemulapalli
SKShun Kohsaka
Shun Kohsaka
KSKazuo Shimamura
Kazuo Shimamura
ASAmanda Stebbins
Amanda Stebbins
ASAnd Yoshiki Sawa
And Yoshiki Sawa
Background: The practice pattern and outcome of medical devices following their regulatory approval may differ by country. The aim of this study is to compare postapproval national clinical registry data on transcatheter aortic valve replacement between the United States and Japan on patient characteristics, periprocedural outcomes, and the variability of outcomes as a part of a partnership program (Harmonization‐by‐Doing) between the 2 countries. Methods and Results: The patient‐level data were extracted from the US Society of Thoracic Surgeons /American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) and the J‐TVT (Japanese Transcatheter Valvular Therapy) registry, respectively, to analyze transcatheter aortic valve replacement outcomes between 2013 and 2019. Data entry for these registries was mandated by the federal regulators, and the majority of variable definitions were harmonized to allow direct data comparison. A total of 244 722 transcatheter aortic valve replacements from 646 institutions in the United States and 26 673 transcatheter aortic valve replacements from 171 institutions in Japan were analyzed. Median volume per site was 65 (interquartile range, 45–97) in the United States and 28 (interquartile range, 19–41) in Japan. Overall, patients in J‐TVT were older (United States: mean‐age, 80.1±8.7 versus Japan: 84.4±5.2; P <0.001), were more frequently women (45.9% versus 68.1%; P <0.001), and had higher median Society of Thoracic Surgeons Predicted Risk of Mortality (5.27% versus 6.20%; P <0.001) than patients in the United States. Japan had lower unadjusted 30‐day mortality (1.3% versus 3.2%; P <0.001) and composite outcomes of death, stroke, and bleeding (17.5 versus 22.5%; P <0.001) but had higher conversion to open surgery (0.94% versus 0.56%; P <0.001). Conclusions: This collaborative analysis between the United States and Japan demonstrated the feasibility of international comparison using the national registries coded under mutual variable definitions. Both countries obtained excellent outcomes, although the Japanese had lower 30‐day mortality and major morbidity. Harmonization‐by‐Doing is one of the key steps needed to build global‐level learning to improve patient outcomes.

16 February 2018 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
AAAdel Aminian
Adel Aminian
SSShigeru Saito
Shigeru Saito
ATAkihiko Takahashi
Akihiko Takahashi
IBIvo Bernat
Ivo Bernat
RJRobert Lee Jobe
Robert Lee Jobe
SRSunil V. Rao
Sunil V. Rao
Background: During transradial (TR) access, it remains unclear whether differences in baseline patients characteristics and hemostasis care impact the rate of radial artery occlusion (RAO). We sought to compare the rate of RAO after TR access with the 6 French(Fr) Glidesheath Slender (GSS6Fr, Terumo, Japan) or a standard 5 Fr sheath in Japanese and non‐Japanese patients.Methods and Results: The Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial randomized 1,836 patients undergoing TR coronary angiography and/or interventions to receive the GSS6Fr or the standard 5 Fr Glidesheath (GS5Fr, Terumo, Japan). Out of this study population, 1,087 were Japanese patients and 751 non‐Japanese patients. The overall incidence of RAO was significantly higher in Japanese patients (3.6% vs. 1.2%, P = 0.002). Use of GSS6Fr was associated with higher rates of RAO than GS5Fr in Japanese patients (5% vs. 2.2%, P = 0.02) and with similar RAO rates in non‐Japanese patients (1.3 vs. 1.1%, P = 1). The mean hemostasis time was significantly longer in Japanese patients (378 ± 253 vs. 159 ± 136 min, P < 0.001) and more Japanese patients had a hemostasis time of more than 6 hr (16.2% vs. 4.9%, P < 0.0001). Longer hemostasis time was an independent predictor of RAO (OR per additional hour 1.070, 95% CI 1.008–1.136, P = 0.03).Conclusions: Use of GSS6Fr was associated with a higher rate of RAO than a standard 5 Fr sheath in Japanese patients but not in non‐Japanese patients. Whether improvement in post‐procedural care and reduced hemostasis time could impact the incidence of RAO in Japanese patients should be further assessed.